ACTINIUM PHARMACEUTICALS, INC. Operating Expenses
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Operating Expenses of $7.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-06-30 was $7.43M, a 0.91% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-03-31 was $5.90M, a 64.52% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-12-31 was $6.41M, a 14.54% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-09-30 was $5.78M, a 54.11% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for fiscal 2025 was $36.34M, a 13.73% decline from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for fiscal 2024 was $42.12M, a 19.00% decline from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for fiscal 2023 was $52.00M, a 48.01% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $35.13M, a 34.57% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 151 month | Operating Expenses 154 month | Operating Expenses 157 month | Operating Expenses 160 month | Operating Expenses 163 month | Operating Expenses 166 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.43M 10-Q · filed 2026-08-07 | $13.34M 10-Q · filed 2026-08-07 | $19.75M derived: sum of 3 quarters · filed 2026-08-07 | $25.53M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2026-03-31 | $5.90M 10-Q · filed 2026-05-08 | $12.32M derived: sum of 2 quarters · filed 2026-05-08 | $18.10M derived: sum of 3 quarters · filed 2026-05-08 | $25.60M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2025-12-31 | $6.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $12.20M derived: sum of 2 quarters · filed 2026-03-30 | $19.70M derived: sum of 3 quarters · filed 2026-08-07 | $36.34M 10-K · filed 2026-03-30 | ||||||||||
| 2025-09-30 | $5.78M 10-Q · filed 2025-11-14 | $13.29M derived: sum of 2 quarters · filed 2026-08-07 | $29.92M 10-Q · filed 2025-11-14 | $37.43M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2025-06-30 | $7.50M 10-Q · filed 2026-08-07 | $24.14M 10-Q · filed 2026-08-07 | $31.65M derived: sum of 3 quarters · filed 2026-08-07 | $44.25M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2025-03-31 | $16.64M 10-Q · filed 2026-05-08 | $24.14M derived: sum of 2 quarters · filed 2026-05-08 | $36.74M derived: sum of 3 quarters · filed 2026-05-08 | $49.16M derived: sum of 4 quarters · filed 2026-05-08 | ||||||||||
| 2024-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $20.11M derived: sum of 2 quarters · filed 2026-03-30 | $32.52M derived: sum of 3 quarters · filed 2026-03-30 | $42.12M 10-K · filed 2026-03-30 | ||||||||||
| 2024-09-30 | $12.60M 10-Q · filed 2025-11-14 | $25.02M derived: sum of 2 quarters · filed 2025-11-14 | $34.62M 10-Q · filed 2025-11-14 | $45.04M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||
| 2024-06-30 | $12.42M 10-Q · filed 2025-08-08 | $22.02M 10-Q · filed 2025-08-08 | $32.44M derived: sum of 3 quarters · filed 2025-08-08 | $46.79M derived: sum of 4 quarters · filed 2025-08-08 | ||||||||||
| 2024-03-31 | $9.60M 10-Q · filed 2025-05-09 | $20.02M derived: sum of 2 quarters · filed 2025-05-09 | $34.37M derived: sum of 3 quarters · filed 2025-05-09 | $50.01M derived: sum of 4 quarters · filed 2025-05-09 | ||||||||||
| 2023-12-31 | $10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $24.77M derived: sum of 2 quarters · filed 2025-03-31 | $40.42M derived: sum of 3 quarters · filed 2025-03-31 | $52.00M 10-K · filed 2025-03-31 | ||||||||||
| 2023-09-30 | $14.35M 10-Q · filed 2024-11-14 | $29.99M derived: sum of 2 quarters · filed 2024-11-14 | $41.58M 10-Q · filed 2024-11-14 | $52.87M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||
| 2023-06-30 | $15.64M 10-Q · filed 2024-08-05 | $27.23M 10-Q · filed 2024-08-05 | $38.52M derived: sum of 3 quarters · filed 2024-08-05 | $48.36M derived: sum of 4 quarters · filed 2024-08-05 | ||||||||||
| 2023-03-31 | $11.58M 10-Q · filed 2024-04-26 | $22.88M derived: sum of 2 quarters · filed 2024-04-26 | $32.72M derived: sum of 3 quarters · filed 2024-04-26 | $40.61M derived: sum of 4 quarters · filed 2024-04-26 | ||||||||||
| 2022-12-31 | $11.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $21.14M derived: sum of 2 quarters · filed 2024-03-29 | $29.03M derived: sum of 3 quarters · filed 2024-03-29 | $35.13M 10-K · filed 2024-03-29 | ||||||||||
| 2022-09-30 | $9.84M 10-Q · filed 2023-11-02 | $17.74M derived: sum of 2 quarters · filed 2023-11-02 | $23.84M 10-Q · filed 2023-11-02 | $31.91M derived: sum of 4 quarters · filed 2023-11-02 | ||||||||||
| 2022-06-30 | $7.89M 10-Q · filed 2023-08-14 | $14.00M 10-Q · filed 2023-08-14 | $22.07M derived: sum of 3 quarters · filed 2023-08-14 | $28.77M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||
| 2022-03-31 | $6.10M 10-Q · filed 2023-05-15 | $14.18M derived: sum of 2 quarters · filed 2023-05-15 | $20.88M derived: sum of 3 quarters · filed 2023-05-15 | $26.22M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||
| 2021-12-31 | $8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $14.77M derived: sum of 2 quarters · filed 2023-03-31 | $20.11M derived: sum of 3 quarters · filed 2023-03-31 | $26.11M 10-K · filed 2023-03-31 | ||||||||||
| 2021-09-30 | $6.70M 10-Q · filed 2022-11-14 | $12.04M derived: sum of 2 quarters · filed 2022-11-14 | $18.04M 10-Q · filed 2022-11-14 | $24.47M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||
| 2021-06-30 | $5.34M 10-Q · filed 2022-08-12 | $11.34M 10-Q · filed 2022-08-12 | $17.77M derived: sum of 3 quarters · filed 2022-08-12 | $23.38M derived: sum of 4 quarters · filed 2022-08-12 | ||||||||||
| 2021-03-31 | $5.99M 10-Q · filed 2022-05-13 | $12.43M derived: sum of 2 quarters · filed 2022-05-13 | $18.04M derived: sum of 3 quarters · filed 2022-05-13 | $22.70M derived: sum of 4 quarters · filed 2022-05-13 | ||||||||||
| 2020-12-31 | $6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $12.05M derived: sum of 2 quarters · filed 2022-03-25 | $16.71M derived: sum of 3 quarters · filed 2022-03-25 | $22.39M 10-K · filed 2022-03-25 | ||||||||||
| 2020-09-30 | $5.61M 10-Q · filed 2021-11-12 | $10.28M derived: sum of 2 quarters · filed 2021-11-12 | $15.96M 10-Q · filed 2021-11-12 | $20.59M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||
| 2020-06-30 | $4.66M 10-Q · filed 2021-07-30 | $10.35M 10-Q · filed 2021-07-30 | $14.98M derived: sum of 3 quarters · filed 2021-07-30 | $21.63M derived: sum of 4 quarters · filed 2021-07-30 | ||||||||||
| 2020-03-31 | $5.68M 10-Q · filed 2021-05-14 | $10.32M derived: sum of 2 quarters · filed 2021-05-14 | $16.97M derived: sum of 3 quarters · filed 2021-05-14 | $22.05M derived: sum of 4 quarters · filed 2021-05-14 | ||||||||||
| 2019-12-31 | $4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $11.29M derived: sum of 2 quarters · filed 2021-03-31 | $16.37M derived: sum of 3 quarters · filed 2021-03-31 | $22.07M 10-K · filed 2021-03-31 | $22.07M 10-K · filed 2020-05-08 | |||||||||
| 2019-09-30 | $6.65M 10-Q · filed 2020-10-23 | $6.65M 10-Q · filed 2019-11-12 | $11.74M derived: sum of 2 quarters · filed 2020-10-23 | $17.44M 10-Q · filed 2020-10-23 | $17.44M 10-Q · filed 2019-11-12 | $23.80M derived: sum of 4 quarters · filed 2020-10-23 | ||||||||
| 2019-06-30 | $5.09M 10-Q · filed 2020-08-14 | $5.09M 10-Q · filed 2019-08-09 | $10.79M 10-Q · filed 2020-08-14 | $10.79M 10-Q · filed 2019-08-09 | $17.15M derived: sum of 3 quarters · filed 2020-08-14 | $23.35M derived: sum of 4 quarters · filed 2020-08-14 | ||||||||
| 2019-03-31 | $5.70M 10-Q · filed 2020-06-29 | $5.70M 10-Q · filed 2019-05-10 | $12.06M derived: sum of 2 quarters · filed 2020-06-29 | $18.26M derived: sum of 3 quarters · filed 2020-06-29 | $23.17M derived: sum of 4 quarters · filed 2020-06-29 | |||||||||
| 2018-12-31 | $6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | $12.56M derived: sum of 2 quarters · filed 2020-05-08 | $17.47M derived: sum of 3 quarters · filed 2020-05-08 | $23.83M 10-K · filed 2020-05-08 | ||||||||||
| 2018-09-30 | $6.20M 10-Q · filed 2019-11-12 | $11.11M derived: sum of 2 quarters · filed 2019-11-12 | $17.46M 10-Q · filed 2019-11-12 | $22.67M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||
| 2018-06-30 | $4.91M 10-Q · filed 2019-08-09 | $11.27M 10-Q · filed 2019-08-09 | $16.47M derived: sum of 3 quarters · filed 2019-08-09 | $23.17M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||
| 2018-03-31 | $6.35M 10-Q · filed 2019-05-10 | $11.56M derived: sum of 2 quarters · filed 2019-05-10 | $18.26M derived: sum of 3 quarters · filed 2019-05-10 | $25.46M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||
| 2017-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $11.90M derived: sum of 2 quarters · filed 2019-03-15 | $19.11M derived: sum of 3 quarters · filed 2019-03-15 | $26.91M 10-K · filed 2019-03-15 | ||||||||||
| 2017-09-30 | $6.70M 10-Q · filed 2018-11-09 | $13.90M derived: sum of 2 quarters · filed 2018-11-09 | $21.70M 10-Q · filed 2018-11-09 | $28.53M derived: sum of 4 quarters · filed 2019-03-15 | ||||||||||
| 2017-06-30 | $7.20M 10-Q · filed 2018-08-09 | $15.01M 10-Q · filed 2018-08-09 | $21.84M derived: sum of 3 quarters · filed 2019-03-15 | $28.94M derived: sum of 4 quarters · filed 2019-03-15 | ||||||||||
| 2017-03-31 | $7.81M 10-Q · filed 2018-05-10 | $14.63M derived: sum of 2 quarters · filed 2019-03-15 | $21.73M derived: sum of 3 quarters · filed 2019-03-15 | $28.65M derived: sum of 4 quarters · filed 2019-03-15 | ||||||||||
| 2016-12-31 | $6.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $13.93M derived: sum of 2 quarters · filed 2019-03-15 | $20.85M derived: sum of 3 quarters · filed 2019-03-15 | $26.85M 10-K · filed 2019-03-15 | ||||||||||
| 2016-09-30 | $7.10M 10-Q · filed 2017-11-03 | $14.02M derived: sum of 2 quarters · filed 2017-11-03 | $20.02M 10-Q · filed 2017-11-03 | $24.94M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||
| 2016-06-30 | $6.92M 10-Q · filed 2017-08-04 | $12.92M 10-Q · filed 2017-08-04 | $17.84M derived: sum of 3 quarters · filed 2018-03-16 | $22.48M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||
| 2016-03-31 | $6.00M 10-Q · filed 2017-05-15 | $10.92M derived: sum of 2 quarters · filed 2018-03-16 | $15.56M derived: sum of 3 quarters · filed 2018-03-16 | $22.97M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||
| 2015-12-31 | $4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $9.56M derived: sum of 2 quarters · filed 2018-03-16 | $16.96M derived: sum of 3 quarters · filed 2018-03-16 | $24.83M 10-K · filed 2018-03-16 | ||||||||||
| 2015-09-30 | $4.64M 10-Q · filed 2016-10-28 | $12.04M derived: sum of 2 quarters · filed 2016-10-28 | $19.91M 10-Q · filed 2016-10-28 | $26.78M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2015-06-30 | $7.40M 10-Q · filed 2016-07-29 | $15.27M 10-Q · filed 2016-07-29 | $22.14M derived: sum of 3 quarters · filed 2017-03-16 | $29.19M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2015-03-31 | $7.87M 10-Q · filed 2016-05-10 | $14.74M derived: sum of 2 quarters · filed 2017-03-16 | $21.78M derived: sum of 3 quarters · filed 2017-03-16 | $26.21M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2014-12-31 | $6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $13.92M derived: sum of 2 quarters · filed 2017-03-16 | $18.34M derived: sum of 3 quarters · filed 2017-03-16 | $22.48M 10-K · filed 2017-03-16 | ||||||||||
| 2014-09-30 | $7.04M 10-Q · filed 2015-10-30 | $11.47M derived: sum of 2 quarters · filed 2015-10-30 | $15.61M 10-Q · filed 2015-10-30 | $17.09M derived: sum of 4 quarters · filed 2016-03-11 | ||||||||||
| 2014-06-30 | $4.42M 10-Q · filed 2015-08-07 | $8.56M 10-Q · filed 2015-08-07 | $10.05M derived: sum of 3 quarters · filed 2016-03-11 | $11.66M derived: sum of 4 quarters · filed 2016-03-11 | ||||||||||
| 2014-03-31 | $4.14M 10-Q · filed 2015-05-08 | $5.62M derived: sum of 2 quarters · filed 2016-03-11 | $7.23M derived: sum of 3 quarters · filed 2016-03-11 | $8.71M derived: sum of 4 quarters · filed 2016-03-11 | $65.47M 10-Q · filed 2014-05-12 | |||||||||
| 2013-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $3.09M derived: sum of 2 quarters · filed 2016-03-11 | $4.57M derived: sum of 3 quarters · filed 2016-03-11 | $6.59M 10-K · filed 2016-03-11 | $61.33M 10-K · filed 2014-02-28 | |||||||||
| 2013-09-30 | $1.61M 10-Q · filed 2014-10-31 | $3.08M derived: sum of 2 quarters · filed 2014-10-31 | $5.11M 10-Q · filed 2014-10-31 | $8.81M derived: sum of 4 quarters · filed 2014-10-31 | $59.85M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $1.48M 10-Q · filed 2014-08-12 | $3.50M 10-Q · filed 2014-08-12 | $7.20M derived: sum of 3 quarters · filed 2014-08-12 | $9.60M derived: sum of 4 quarters · filed 2014-08-12 | $56.24M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $2.02M 10-Q · filed 2014-05-12 | $5.73M derived: sum of 2 quarters · filed 2014-05-12 | $8.13M derived: sum of 3 quarters · filed 2014-05-12 | $8.96M derived: sum of 4 quarters · filed 2014-05-12 | $56.76M 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $6.10M derived: sum of 2 quarters · filed 2014-02-28 | $6.94M derived: sum of 3 quarters · filed 2014-02-28 | $7.95M 10-K · filed 2014-02-28 | $54.74M 10-K · filed 2013-03-29 | |||||||||
| 2012-09-30 | $2.40M 10-Q · filed 2013-11-14 | $3.24M derived: sum of 2 quarters · filed 2013-11-14 | $4.24M 10-Q · filed 2013-11-14 | $15.62K 10-Q · filed 2012-11-14 | $4.25M derived: sum of 4 quarters · filed 2013-11-14 | |||||||||
| 2012-06-30 | $839.34K 10-Q · filed 2013-08-13 | $1.84M 10-Q · filed 2013-08-13 | $13.35K 10-Q/A · filed 2012-08-29 | $1.85M derived: sum of 3 quarters · filed 2013-08-13 | $1.85M derived: sum of 4 quarters · filed 2013-08-13 | |||||||||
| 2012-03-31 | $1.01M 10-Q · filed 2013-05-15 | $8.42K 10-Q · filed 2012-04-23 | $1.01M derived: sum of 2 quarters · filed 2013-05-15 | $1.01M derived: sum of 3 quarters · filed 2013-05-15 | ||||||||||
| 2011-12-31 | $2.68K 10-Q · filed 2012-04-23 | $5.11K derived: sum of 2 quarters · filed 2012-11-14 | $3.28M 10-K · filed 2013-03-29 | $9.95K 10-K · filed 2012-04-12 | ||||||||||
| 2011-09-30 | $2.43K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $8.47K 10-Q · filed 2012-11-14 | ||||||||||||
| 2011-06-30 | $6.04K 10-Q/A · filed 2012-08-29 | |||||||||||||
| 2010-12-31 | $7.24K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-12 | $15.36K derived: sum of 2 quarters · filed 2012-04-12 | $26.05K 10-K · filed 2012-04-12 | |||||||||||
| 2010-09-30 | $8.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $18.82K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $10.69K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |